Ross RK - Search Results

1

Evidence of an X-linked or recessive genetic component to prostate cancer risk.

Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Monroe KR, et al. Among authors: ross rk. Nat Med. 1995 Aug;1(8):827-9. doi: 10.1038/nm0895-827. Nat Med. 1995. PMID: 7585188

2

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Reichardt JK, et al. Among authors: ross rk. Cancer Res. 1995 Sep 15;55(18):3973-5. Cancer Res. 1995. PMID: 7664265

3

The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

Irvine RA, Yu MC, Ross RK, Coetzee GA. Irvine RA, et al. Among authors: ross rk. Cancer Res. 1995 May 1;55(9):1937-40. Cancer Res. 1995. PMID: 7728763

4

Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.

Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. Yu MC, et al. Among authors: ross rk. J Natl Cancer Inst. 1994 May 4;86(9):712-6. doi: 10.1093/jnci/86.9.712. J Natl Cancer Inst. 1994. PMID: 8158701

5

Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.

Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, Coetzee GA. Yu MC, et al. Among authors: ross rk. Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):861-4. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 8634658

6

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Ingles SA, et al. Among authors: ross rk. J Natl Cancer Inst. 1997 Jan 15;89(2):166-70. doi: 10.1093/jnci/89.2.166. J Natl Cancer Inst. 1997. PMID: 8998186

7

Genetic susceptibility to cancer from exogenous and endogenous exposures.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. Among authors: ross rk. J Cell Biochem Suppl. 1996;25:15-22. doi: 10.1002/(sici)1097-4644(1996)25+<15::aid-jcb2>3.0.co;2-5. J Cell Biochem Suppl. 1996. PMID: 9027593 Review.

8

A polymorphism in the CYP17 gene increases the risk of breast cancer.

Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. Feigelson HS, et al. Among authors: ross rk. Cancer Res. 1997 Mar 15;57(6):1063-5. Cancer Res. 1997. PMID: 9067272

9

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk.

Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK, Reichardt JK. Devgan SA, et al. Among authors: ross rk. Prostate. 1997 Sep 15;33(1):9-12. doi: 10.1002/(sici)1097-0045(19970915)33:1<9::aid-pros2>3.0.co;2-h. Prostate. 1997. PMID: 9294620

10

Association of prostate cancer with vitamin D receptor haplotypes in African-Americans.

Ingles SA, Coetzee GA, Ross RK, Henderson BE, Kolonel LN, Crocitto L, Wang W, Haile RW. Ingles SA, et al. Among authors: ross rk. Cancer Res. 1998 Apr 15;58(8):1620-3. Cancer Res. 1998. PMID: 9563471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters